Skip Nav Destination
RESEARCH
COVID-19, Hormones and Brain
Neuroimmunomodulation article collection edited by Prof. Maurizio Cutolo – University of Genova, Genova, Italy.
With the COVID-19 pandemic not yet over several links are emerging concerning the brain reactivity and the severity of the SARS-CoV2 infection. The brain as target of the long COVID symptomatology seems one of the most evident sequelae among the survivors. On the other hands, the gender seems to influence the severity of the SARS-CoV2 infection, with higher protection in males during the early phases of the inflammatory reaction but with higher mortality in male patients over the longer time. This collection of updated reviews on the theme COVID-19, hormones and brain, adds important contributions to such progressing and complex interplay.
-
Emre Durcan; Aysa Hacioglu; Zuleyha Karaca; Kursad Unluhizarci; Mustafa Sait Gonen; Fahrettin Kelestimur
Neuroimmunomodulation (2023) 30 (1): 215–225. (DOI:10.1159/000534025) -
Aliki Karkala; Asterios Tzinas; Seraphim Kotoulas; Athanasios Zacharias; Evdokia Sourla; Athanasia Pataka
Neuroimmunomodulation (2023) 30 (1): 237–249. (DOI:10.1159/000533722) -
Emanuele Gotelli; Stefano Soldano; Elvis Hysa; Andrea Casabella; Andrea Cere; Carmen Pizzorni; Sabrina Paolino; Alberto Sulli; Vanessa Smith; Maurizio Cutolo
Neuroimmunomodulation (2023) 30 (1): 185–195 (DOI:10.1159/000533286) -
Larissa Joaquim; Amanda Della Giustina; Richard Simon Machado; Kiuanne Lino Lobo Metzker; Sandra Bonfante; Lucineia Gainski Danielski; Mariana Pereira de Souza Goldim; Fabricia Petronilho
Neuroimmunomodulation (2022) 29 (4): 269–281 (DOI:10.1159/000526653) -
Muhammad Mubashshir; Nabeel Ahmad; Tripti Negi; Renu Rawal; Nirjara Singhvi; Hina Khatoon; Vijya Laxmi; Om Dubey; Renu Bala Sharma; Ganga Negi; Mohd Ovais
Neuroimmunomodulation (2023) 30 (1): 196–205 (DOI:10.1159/000531550)